|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 9700 W. BRYN MAWR AVENUE |
Address2 |
|
| City | ROSEMONT |
State | IL |
Zip Code | 60018-5701 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1672-24
|
||||||||
|
6. House ID# 317140000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Jeanne Tuerk |
Date | 7/15/2020 5:08:06 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
-In support of the RAISE Health Benefits Act (S 503/HR 1366) - expanding the use of FSAs
-In support of the Health Savings Act (S 12) - expanding the use of HSAs
-In support of the Oral Health Literacy and Awareness Act of 2019 (H.R.4678) - authorizes HRSA to develop a 5-year evidence-based oral health literacy campaign across the agencys relevant program.
-Asking for assistance in securing access for OMSs to N95 masks during COVID-19 pandemic
-Asking HHS to provide federal authorization for licensed dentists to conduct FDA authorized point-of-case testing for COVID-19.
-Asking CDC to consider AAOMS's comments on their May 19 Interim Infection Prevention and Control Guidance for Dental Settings During the COVID-19 Response
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Federal Emergency Management Agency (FEMA), White House Office, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Tuerk |
|
|
|
Sandra |
Guenther |
|
|
|
Karin |
Wittich |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
In support of the Competitive Health Insurance Reform Act of 2019 (HR 1418/S 350) - antitrust reform
In support of the Ensuring Lasting Smiles Act (HR 1379/S 560) - insurance coverage for patients with congenital anomalies
Shared with members of Congress the association's principals related to surprise billing occurrences.
In support of the Dental and Optometric (DOC) Access Act (HR 3762) to prohibit "non-covered services" provisions in dental and vision plans and coverage.
Ask Congress to pass Business Interruption Insurance Coverage Act (HR 6494) to enhance business interruption insurance policies related to COVID-19.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sandra |
Guenther |
|
|
|
Jeanne |
Tuerk |
|
|
|
Karin |
Wittich |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
-In support of the Resident Education Deferred Interest Act (HR 1554) - would allow interest free deferment for medical and dental interns and residents
-In support of the POST Grad Act (HR 3418) which would reinstate eligibility for graduate and professional students with financial need to receive Direct Subsidized Stafford Loans.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sandra |
Guenther |
|
|
|
Jeanne |
Tuerk |
|
|
|
Karin |
Wittich |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
In support of the Protect Medical Innovation Act of 2019 (HR 2207/S 692)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sandra |
Guenther |
|
|
|
Jeanne |
Tuerk |
|
|
|
Karin |
Wittich |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Prescription drug abuse prevention - sharing the association's efforts to educate our members.
Communicated with NIDCR and FDA agency staff on opioid abuse efforts and oral cancer awareness issues.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Tuerk |
|
|
|
Karin |
Wittich |
|
|
|
Sandra |
Guenther |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Commented in support of S 1541, the Tobacco-Free Youth Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Tuerk |
|
|
|
Karin |
Wittich |
|
|
|
Sandy |
Guenther |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
-In opposition to the Medicare Dental Act (HR 4650) to expand coverage for certain dental items and services under part B of the Medicare program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Tuerk |
|
|
|
Karin |
Wittich |
|
|
|
Sandy |
Guenther |
|
|
|
Danielle |
Branch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
concerns regarding small business issues related to COVID-19; specifically paid medical/family leave in HR 6201; requesting that associations, nonprofits and other tax-exempt organizations be included within any federal aid packages or supplemental appropriations measures related to COVID-19.
-Asking Treasury, SBA and congressional leaders to allow Paycheck Protection Program loans to be used for personal protective equipment (PPE)
-Asking congressional leaders to allow a tax credit for PPE costs (HR 7216) as well as PPP funds to be used for PPE expenses (S 3833) and (S 3716)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Labor - Dept of (DOL), Small Business Administration (SBA), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Karin |
Wittich |
|
|
|
Jeanne |
Tuerk |
|
|
|
Danielle |
Branch |
|
|
|
Sandra |
Guenther |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
-Ask Congress to extend immunity liability for all healthcare providers involved in providing care during the COVID-19 pandemic.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Tuerk |
|
|
|
Danielle |
Branch |
|
|
|
Karin |
Wittich |
|
|
|
Sandra |
Guenther |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |